1. Articles from biospace.com

  2. 1-24 of 74 1 2 3 »
    1. Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership Team

      Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership Team

      WALTHAM, Mass.--(BUSINESS WIRE)-- Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of Scott Brun M.D. to its Board of Directors...

      Read Full Article
    2. BeyondSpring Appoints Pharma Veterans Drs. Daniel Zabrowski and Ramon Mohanlal to Company’s Board of Directors

      BeyondSpring Appoints Pharma Veterans Drs. Daniel Zabrowski and Ramon Mohanlal to Company’s Board of Directors

      NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced the appointments of Drs. Daniel Zabrowski and Ramon Mohanlal to the Company’s Board of Directors...

       

      Read Full Article
    3. Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors

      Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors

      CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foghorn® Therapeutics Inc. (Foghorn), a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulatory system, today appointed Scott Biller, Ph.D., to its Board of Directors...

      Read Full Article
    4. Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors

      Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors

      SOUTH SAN FRANCISCO, Calif., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Kezar Life SciencesInc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, today announced the appointment of Elizabeth Garner, MD, MPH to its Board of Directors. Dr. Garner is currently the Chief Medical Officer of ObsEva SA...

      Read Full Article
    5. IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors

      IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors

      SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointment of Wendy L. Yarno as a Director of its Board of Directors...

      Read Full Article
    6. Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

      Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

      RADNOR, Pa., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric disorders, announced today that Elan Ezickson, has joined the Company’s Board of Directors...

      Read Full Article
    7. ChanceLight Behavioral Health, Therapy and Education Names John McLaughlin, Ph.D., to Board of Directors

      ChanceLight Behavioral Health, Therapy and Education Names John McLaughlin, Ph.D., to Board of Directors

      NASHVILLE, Tenn.Sept. 12, 2019 /PRNewswire/ -- ChanceLight Behavioral Health, Therapy and Education, the nation's leading provider of behavioral health, therapy and education solutions for children and young adults, today announced John McLaughlin, Ph.D., has transitioned from ChanceLight Executive Vice President to a member of the Board of Directors...

      Read Full Article
    8. Aeromics, Inc. Appoints Nobel Laureate Peter Agre to Its Board of Directors

      Aeromics, Inc. Appoints Nobel Laureate Peter Agre to Its Board of Directors

      NEW HAVEN, Conn., Sept. 9, 2019 /PRNewswire/ -- Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company developing first-in-class anti-edema therapies, announced today the appointment of Peter Agre, M.D. to its Board of Directors. Additionally, Dr. Agre will serve as Chair of the newly-formed Science and Technology Subcommittee of the Board of Directors...

      Read Full Article
    9. Cricket Health Names Colleen Reitan to Board of Directors and Adam Hameed as Chief Development Officer

      Cricket Health Names Colleen Reitan to Board of Directors and Adam Hameed as Chief Development Officer

      SAN FRANCISCOAug. 26, 2019 /PRNewswire/ -- Cricket Health, a comprehensive kidney care provider with a personalized, evidence-based approach to managing care, today announced new additions to the company's senior leadership team. Former health plan leader Colleen Reitan was appointed to the company's board of directors and veteran health care executive Adam Hameed will be joining Cricket Health as chief development officer...

      Read Full Article
    10. ChartSpan Announces Addition to Board of Directors, Sarath Degala of BIP Capital

      ChartSpan Announces Addition to Board of Directors, Sarath Degala of BIP Capital

      GREENVILLE, S.C.Aug. 26, 2019 /PRNewswire/ -- Chartspan, the largest Chronic Care Management provider in the United States, has announced that Sarath Degala, Senior Vice President of BIP Capital, has been appointed to its new Board of Directors. BIP Capital is the leader of a five investor syndicate group that recently closed a $15 millionSeries A round of venture capital with ChartSpan. ChartSpan plans to use the funds to scale its operations nationally...

      Read Full Article
    11. Cell BT (CBI) Announces Appointment of Joshua Ofman, M.D., MSHS, to Board of Directors

      Cell BT (CBI) Announces Appointment of Joshua Ofman, M.D., MSHS, to Board of Directors

      LOS ANGELES--(BUSINESS WIRE)-- Cell BT, Inc. (CBI), an immuno-therapy company focused on the discovery and development of innovative cancer therapeutics based on next generation CAR-T antibody constructs directed to novel biological targets, today announced that Joshua J. Ofman, M.D., MSHS, has been appointed to the CBI Board of Directors...

      Read Full Article
    1-24 of 74 1 2 3 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content